B. Neumann

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

M. Uder, A. Cremer, P. Gosse, 2021, The Lancet.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

L. Seeberger, L. Raymond, R. Barker, 2013, JAMA neurology.

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.

Raghava R. Gollapudi, A. Cremer, S. Padmanabhan, 2023, JAMA.